Global Ibuprofen Sodium? API Market Growth 2026-2032

October 2026 | 87 pages | ID: G0E2B33DCF64EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Ibuprofen Sodium? API market size is predicted to grow from US$ 359 million in 2025 to US$ 527 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

Ibuprofen Sodium API refers to the pharmaceutical-grade sodium salt of ibuprofen used as an active pharmaceutical ingredient in finished pharmaceutical formulations. The commercially established form is primarily ibuprofen sodium dihydrate, a racemic sodium salt of ibuprofen supplied as a white to almost-white powder. Compared with conventional ibuprofen, the sodium salt has substantially improved aqueous solubility and dissolution characteristics, making it particularly suitable for formulations designed for rapid drug release and faster absorption. This study focuses on Ibuprofen Sodium API manufactured through chemical synthesis followed by salt formation, purification, crystallization, isolation and appropriate finishing operations. Key product attributes include chemical purity, hydration state, crystallinity, dissolution characteristics, particle properties and regulatory documentation. Its principal downstream applications are rapid-release oral analgesic and antipyretic formulations, including tablets and caplets, as well as selected intravenous and other formulation platforms where higher solubility is technically advantageous. The FDA recognizes ibuprofen sodium and ibuprofen sodium dihydrate as an ibuprofen salt/solvate, while commercial pharmaceutical-grade ibuprofen sodium dihydrate is available as a dedicated API product.

Key Findings

Dihydrate is the principal commercially established Ibuprofen Sodium API form

Higher water solubility supports rapid-release pharmaceutical formulation design

Rapid-release oral analgesics represent a core downstream application

Intravenous formulations provide an additional specialized application pathway

Regulatory documentation and salt-form consistency remain key supplier requirements

Market Trends

Ibuprofen Sodium API is developing as a differentiated salt-form segment within the mature ibuprofen pharmaceutical supply chain rather than as a direct replacement for conventional Ibuprofen API. Product development is increasingly centered on exploiting the sodium salt's improved dissolution characteristics to support rapid-release and fast-acting formulations. Commercial oral medicines already use ibuprofen sodium dihydrate to deliver conventional ibuprofen-equivalent doses, while intravenous formulations demonstrate the value of the salt in applications requiring high aqueous solubility. The longer-term direction of the market is therefore toward formulation-specific API supply, where salt form, hydration state, dissolution behavior and pharmaceutical process compatibility become more important than simple chemical assay. BASF positions ibuprofen sodium dihydrate as a fast-acting ibuprofen grade, while marketed oral products in Europe confirm established use of the sodium dihydrate form in immediate-release tablets and caplets.

Market Dynamics

Drivers

The principal demand driver for Ibuprofen Sodium API is the pharmaceutical industry's need for faster-dissolving ibuprofen formulations. Conventional ibuprofen has relatively limited aqueous solubility, whereas ibuprofen sodium dihydrate is freely soluble in water and dissolves more rapidly, supporting earlier systemic exposure in appropriately designed formulations. This property is commercially relevant in acute pain, headache, fever and other indications where consumers and healthcare providers value rapid onset of action. The large underlying global use of ibuprofen also provides an established therapeutic and regulatory foundation from which differentiated sodium-salt formulations can be developed without changing the active ibuprofen moiety.

Restraints

Demand for Ibuprofen Sodium API is inherently narrower than demand for conventional Ibuprofen API because the sodium salt is primarily selected when rapid dissolution, improved solubility or a particular formulation architecture creates a meaningful product advantage. Standard tablets, capsules, suspensions and many other conventional ibuprofen products can continue to use the parent API, limiting wholesale substitution. The salt form also introduces additional controls around hydration state, crystallization, moisture management and finished-product sodium content. These requirements increase formulation and quality-management complexity and can reduce the economic attractiveness of the sodium form in highly price-sensitive generic products.

Opportunities

The clearest growth opportunities lie in differentiated rapid-release oral analgesics, premium over-the-counter pain-relief products and pharmaceutical formulations where dissolution speed is a meaningful performance attribute. Additional opportunities exist in intravenous preparations and combination products, where aqueous compatibility can provide technical advantages. European regulatory records also demonstrate development activity involving ibuprofen sodium dihydrate in oral granule and intravenous dosage forms, indicating that the molecule can support multiple formulation platforms beyond conventional tablets. Future value creation is therefore likely to concentrate on product reformulation, lifecycle management and differentiated delivery rather than expansion through undifferentiated bulk API consumption.

Challenges

The main challenge is converting the physicochemical advantage of Ibuprofen Sodium API into a commercially meaningful finished-product benefit while maintaining acceptable manufacturing cost. Faster dissolution alone does not guarantee superior market positioning, as product performance must be demonstrated within the finished dosage form and supported by appropriate regulatory documentation. API manufacturers must also maintain consistent salt formation, hydration state, purity, crystallization and physical characteristics across batches. At the customer level, formulation changes or API-source changes can require additional development, stability, validation and regulatory work, creating relatively long qualification cycles and limiting rapid supplier substitution.

Industry Chain Analysis

The upstream chain for Ibuprofen Sodium API begins with the chemical intermediates and manufacturing inputs used to produce pharmaceutical-grade ibuprofen, followed by sodium-containing reagents, process solvents, purification materials and utilities required for salt conversion and finishing. The critical value-added step occurs when the parent ibuprofen molecule is converted into the sodium salt under controlled conditions. Regulatory manufacturing records show that the production process can involve synthesis of active-substance intermediates and crude material, followed by salt formation, purification, crystallization, isolation, drying, milling, blending and sieving. These steps mean that the economics of Ibuprofen Sodium API depend on both the cost of the underlying ibuprofen and the efficiency and reproducibility of salt formation and downstream purification.

The midstream stage covers API conversion, crystallization, hydration-state control, physical processing, analytical testing, packaging and regulatory release. Compared with standard Ibuprofen API, greater value is attached to reliable physicochemical characteristics and formulation performance. Downstream customers are primarily pharmaceutical companies developing fast-release oral analgesics and other dosage forms where improved aqueous behavior creates a measurable formulation benefit. The value chain therefore shifts part of the competitive emphasis from bulk synthesis economics toward salt-form expertise, pharmaceutical quality control, regulatory support and formulation compatibility.

Segment Insights

Within Ibuprofen Sodium API, the dihydrate is the most clearly established commercial form in current pharmaceutical applications. FDA substance records identify ibuprofen sodium dihydrate as a defined salt/solvate of ibuprofen, and commercial API documentation confirms pharmaceutical-scale supply of the dihydrate form. The hydrate state is commercially important because it defines molecular composition, handling characteristics and dose conversion between sodium salt and ibuprofen base. For example, marketed oral products use 256 mg of ibuprofen sodium dihydrate to provide the equivalent of 200 mg of ibuprofen, illustrating how the salt form is incorporated into finished-product design.

From an application perspective, rapid-release oral solid formulations currently represent the most visible commercial segment, supported by established tablet and caplet products. Intravenous use represents a smaller but technically differentiated direction, where the improved aqueous characteristics of the sodium salt are particularly relevant. This structure suggests that future segmentation will continue to be driven less by simple API purity grades and more by dosage-form requirements, formulation performance and regulatory-market qualification.

Downstream Market Opportunities

The most attractive downstream opportunity for Ibuprofen Sodium API is the fast-acting analgesic segment, particularly oral products positioned around rapid dissolution and early pain relief. Existing 200 mg-equivalent and 400 mg-equivalent tablet presentations demonstrate that the sodium salt can be incorporated into familiar consumer dosage strengths while offering a differentiated formulation platform. Beyond oral tablets and caplets, intravenous combination medicines and development programs involving oral granules show additional potential for the API. These applications are unlikely to replace conventional ibuprofen across the entire market, but they create a higher-value niche in which API functionality, formulation performance and regulatory support can outweigh pure kilogram-level procurement cost.

Regional Insights

Europe represents a clearly established commercialization region for Ibuprofen Sodium API-based rapid-release oral medicines. Regulatory product information in the United Kingdom confirms multiple marketed tablet and caplet presentations containing ibuprofen sodium dihydrate, while European Medicines Agency records also identify the sodium dihydrate form in oral and intravenous development programs. These examples indicate a relatively mature regulatory and formulation pathway for sodium-salt ibuprofen products in the European pharmaceutical market.

North America also represents an important specialized market. The FDA maintains a validated substance record for Ibuprofen Sodium, and an FDA-approved intravenous combination medicine uses ibuprofen sodium dihydrate as the source of ibuprofen. At the supply level, pharmaceutical-grade ibuprofen sodium dihydrate is produced for regulated-market customers with dedicated regulatory documentation. In other regions, opportunities are likely to depend on the development of premium rapid-release products and the willingness of local pharmaceutical companies to differentiate from low-cost conventional ibuprofen formulations rather than on broad substitution of the parent API.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Ibuprofen Sodium? API Industry Forecast” looks at past sales and reviews total world Ibuprofen Sodium? API sales in 2025, providing a comprehensive analysis by region and market sector of projected Ibuprofen Sodium? API sales for 2026 through 2032. With Ibuprofen Sodium? API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ibuprofen Sodium? API industry.

This Insight Report provides a comprehensive analysis of the global Ibuprofen Sodium? API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ibuprofen Sodium? API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ibuprofen Sodium? API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ibuprofen Sodium? API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ibuprofen Sodium? API.

This report presents a comprehensive overview, market shares, and growth opportunities of Ibuprofen Sodium? API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • USP
  • EP

Segmentation by Physical Processing:

  • Standard Crystalline
  • Micronized

Segmentation by Regulatory Market Positioning:

  • Regulated-Market
  • General GMP Export
  • Other

Segmentation by Application:

  • Tablet
  • Capsule
  • Suspension
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Xinhua Pharmaceutical
  • IOLCP
  • Granules Biocause
  • Strides Shasun
  • BASF
  • SI Group
  • Hisoar
  • Granules India
  • SMS Pharmaceuticals
  • Luna Chemical Industries

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Ibuprofen Sodium? API market?
  • What factors are driving Ibuprofen Sodium? API market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Ibuprofen Sodium? API market opportunities vary by end market size?
  • How does Ibuprofen Sodium? API break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ibuprofen Sodium? API Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Ibuprofen Sodium? API by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Ibuprofen Sodium? API by Country/Region, 2021, 2025 & 2032
2.2 Ibuprofen Sodium? API Segment by Type
  2.2.1 USP
  2.2.2 EP
  2.2.3 Ibuprofen Sodium? API Sales by Type
    2.2.3.1 Global Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Ibuprofen Sodium? API Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Ibuprofen Sodium? API Sale Price by Type (2021-2026)
2.3 Ibuprofen Sodium? API Segment by Physical Processing
  2.3.1 Standard Crystalline
  2.3.2 Micronized
  2.3.3 Ibuprofen Sodium? API Sales by Physical Processing
    2.3.3.1 Global Ibuprofen Sodium? API Sales Market Share by Physical Processing (2021-2026)
    2.3.3.2 Global Ibuprofen Sodium? API Revenue and Market Share by Physical Processing (2021-2026)
    2.3.3.3 Global Ibuprofen Sodium? API Sale Price by Physical Processing (2021-2026)
2.4 Ibuprofen Sodium? API Segment by Regulatory Market Positioning
  2.4.1 Regulated-Market
  2.4.2 General GMP Export
  2.4.3 Other
  2.4.4 Ibuprofen Sodium? API Sales by Regulatory Market Positioning
    2.4.4.1 Global Ibuprofen Sodium? API Sales Market Share by Regulatory Market Positioning (2021-2026)
    2.4.4.2 Global Ibuprofen Sodium? API Revenue and Market Share by Regulatory Market Positioning (2021-2026)
    2.4.4.3 Global Ibuprofen Sodium? API Sale Price by Regulatory Market Positioning (2021-2026)
2.5 Ibuprofen Sodium? API Segment by Application
  2.5.1 Tablet
  2.5.2 Capsule
  2.5.3 Suspension
  2.5.4 Other
  2.5.5 Ibuprofen Sodium? API Sales by Application
    2.5.5.1 Global Ibuprofen Sodium? API Sale Market Share by Application (2021-2026)
    2.5.5.2 Global Ibuprofen Sodium? API Revenue and Market Share by Application (2021-2026)
    2.5.5.3 Global Ibuprofen Sodium? API Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Ibuprofen Sodium? API Breakdown Data by Company
  3.1.1 Global Ibuprofen Sodium? API Annual Sales by Company (2021-2026)
  3.1.2 Global Ibuprofen Sodium? API Sales Market Share by Company (2021-2026)
3.2 Global Ibuprofen Sodium? API Annual Revenue by Company (2021-2026)
  3.2.1 Global Ibuprofen Sodium? API Revenue by Company (2021-2026)
  3.2.2 Global Ibuprofen Sodium? API Revenue Market Share by Company (2021-2026)
3.3 Global Ibuprofen Sodium? API Sale Price by Company
3.4 Key Manufacturers Ibuprofen Sodium? API Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ibuprofen Sodium? API Product Location Distribution
  3.4.2 Players Ibuprofen Sodium? API Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IBUPROFEN SODIUM? API BY GEOGRAPHIC REGION

4.1 World Historic Ibuprofen Sodium? API Market Size by Geographic Region (2021-2026)
  4.1.1 Global Ibuprofen Sodium? API Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Ibuprofen Sodium? API Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ibuprofen Sodium? API Market Size by Country/Region (2021-2026)
  4.2.1 Global Ibuprofen Sodium? API Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Ibuprofen Sodium? API Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ibuprofen Sodium? API Sales Growth
4.4 APAC Ibuprofen Sodium? API Sales Growth
4.5 Europe Ibuprofen Sodium? API Sales Growth
4.6 Middle East & Africa Ibuprofen Sodium? API Sales Growth

5 AMERICAS

5.1 Americas Ibuprofen Sodium? API Sales by Country
  5.1.1 Americas Ibuprofen Sodium? API Sales by Country (2021-2026)
  5.1.2 Americas Ibuprofen Sodium? API Revenue by Country (2021-2026)
5.2 Americas Ibuprofen Sodium? API Sales by Type (2021-2026)
5.3 Americas Ibuprofen Sodium? API Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ibuprofen Sodium? API Sales by Region
  6.1.1 APAC Ibuprofen Sodium? API Sales by Region (2021-2026)
  6.1.2 APAC Ibuprofen Sodium? API Revenue by Region (2021-2026)
6.2 APAC Ibuprofen Sodium? API Sales by Type (2021-2026)
6.3 APAC Ibuprofen Sodium? API Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ibuprofen Sodium? API by Country
  7.1.1 Europe Ibuprofen Sodium? API Sales by Country (2021-2026)
  7.1.2 Europe Ibuprofen Sodium? API Revenue by Country (2021-2026)
7.2 Europe Ibuprofen Sodium? API Sales by Type (2021-2026)
7.3 Europe Ibuprofen Sodium? API Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ibuprofen Sodium? API by Country
  8.1.1 Middle East & Africa Ibuprofen Sodium? API Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Ibuprofen Sodium? API Revenue by Country (2021-2026)
8.2 Middle East & Africa Ibuprofen Sodium? API Sales by Type (2021-2026)
8.3 Middle East & Africa Ibuprofen Sodium? API Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ibuprofen Sodium? API
10.3 Manufacturing Process Analysis of Ibuprofen Sodium? API
10.4 Industry Chain Structure of Ibuprofen Sodium? API

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ibuprofen Sodium? API Distributors
11.3 Ibuprofen Sodium? API Customer

12 WORLD FORECAST REVIEW FOR IBUPROFEN SODIUM? API BY GEOGRAPHIC REGION

12.1 Global Ibuprofen Sodium? API Market Size Forecast by Region
  12.1.1 Global Ibuprofen Sodium? API Forecast by Region (2027-2032)
  12.1.2 Global Ibuprofen Sodium? API Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ibuprofen Sodium? API Forecast by Type (2027-2032)
12.7 Global Ibuprofen Sodium? API Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Xinhua Pharmaceutical
  13.1.1 Xinhua Pharmaceutical Company Information
  13.1.2 Xinhua Pharmaceutical Ibuprofen Sodium? API Product Portfolios and Specifications
  13.1.3 Xinhua Pharmaceutical Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Xinhua Pharmaceutical Main Business Overview
  13.1.5 Xinhua Pharmaceutical Latest Developments
13.2 IOLCP
  13.2.1 IOLCP Company Information
  13.2.2 IOLCP Ibuprofen Sodium? API Product Portfolios and Specifications
  13.2.3 IOLCP Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 IOLCP Main Business Overview
  13.2.5 IOLCP Latest Developments
13.3 Granules Biocause
  13.3.1 Granules Biocause Company Information
  13.3.2 Granules Biocause Ibuprofen Sodium? API Product Portfolios and Specifications
  13.3.3 Granules Biocause Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Granules Biocause Main Business Overview
  13.3.5 Granules Biocause Latest Developments
13.4 Strides Shasun
  13.4.1 Strides Shasun Company Information
  13.4.2 Strides Shasun Ibuprofen Sodium? API Product Portfolios and Specifications
  13.4.3 Strides Shasun Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Strides Shasun Main Business Overview
  13.4.5 Strides Shasun Latest Developments
13.5 BASF
  13.5.1 BASF Company Information
  13.5.2 BASF Ibuprofen Sodium? API Product Portfolios and Specifications
  13.5.3 BASF Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 BASF Main Business Overview
  13.5.5 BASF Latest Developments
13.6 SI Group
  13.6.1 SI Group Company Information
  13.6.2 SI Group Ibuprofen Sodium? API Product Portfolios and Specifications
  13.6.3 SI Group Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 SI Group Main Business Overview
  13.6.5 SI Group Latest Developments
13.7 Hisoar
  13.7.1 Hisoar Company Information
  13.7.2 Hisoar Ibuprofen Sodium? API Product Portfolios and Specifications
  13.7.3 Hisoar Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Hisoar Main Business Overview
  13.7.5 Hisoar Latest Developments
13.8 Granules India
  13.8.1 Granules India Company Information
  13.8.2 Granules India Ibuprofen Sodium? API Product Portfolios and Specifications
  13.8.3 Granules India Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Granules India Main Business Overview
  13.8.5 Granules India Latest Developments
13.9 SMS Pharmaceuticals
  13.9.1 SMS Pharmaceuticals Company Information
  13.9.2 SMS Pharmaceuticals Ibuprofen Sodium? API Product Portfolios and Specifications
  13.9.3 SMS Pharmaceuticals Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 SMS Pharmaceuticals Main Business Overview
  13.9.5 SMS Pharmaceuticals Latest Developments
13.10 Luna Chemical Industries
  13.10.1 Luna Chemical Industries Company Information
  13.10.2 Luna Chemical Industries Ibuprofen Sodium? API Product Portfolios and Specifications
  13.10.3 Luna Chemical Industries Ibuprofen Sodium? API Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Luna Chemical Industries Main Business Overview
  13.10.5 Luna Chemical Industries Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Ibuprofen Sodium? API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ibuprofen Sodium? API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of USP
Table 4. Major Players of EP
Table 5. Global Ibuprofen Sodium? API Sales by Type (2021-2026) & (Tons)
Table 6. Global Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
Table 7. Global Ibuprofen Sodium? API Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ibuprofen Sodium? API Revenue Market Share by Type (2021-2026)
Table 9. Global Ibuprofen Sodium? API Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Major Players of Standard Crystalline
Table 11. Major Players of Micronized
Table 12. Global Ibuprofen Sodium? API Sales by Physical Processing (2021-2026) & (Tons)
Table 13. Global Ibuprofen Sodium? API Sales Market Share by Physical Processing (2021-2026)
Table 14. Global Ibuprofen Sodium? API Revenue by Physical Processing (2021-2026) & ($ million)
Table 15. Global Ibuprofen Sodium? API Revenue Market Share by Physical Processing (2021-2026)
Table 16. Global Ibuprofen Sodium? API Sale Price by Physical Processing (2021-2026) & (US$/Ton)
Table 17. Major Players of Regulated-Market
Table 18. Major Players of General GMP Export
Table 19. Major Players of Other
Table 20. Global Ibuprofen Sodium? API Sales by Regulatory Market Positioning (2021-2026) & (Tons)
Table 21. Global Ibuprofen Sodium? API Sales Market Share by Regulatory Market Positioning (2021-2026)
Table 22. Global Ibuprofen Sodium? API Revenue by Regulatory Market Positioning (2021-2026) & ($ million)
Table 23. Global Ibuprofen Sodium? API Revenue Market Share by Regulatory Market Positioning (2021-2026)
Table 24. Global Ibuprofen Sodium? API Sale Price by Regulatory Market Positioning (2021-2026) & (US$/Ton)
Table 25. Global Ibuprofen Sodium? API Sale by Application (2021-2026) & (Tons)
Table 26. Global Ibuprofen Sodium? API Sale Market Share by Application (2021-2026)
Table 27. Global Ibuprofen Sodium? API Revenue by Application (2021-2026) & ($ million)
Table 28. Global Ibuprofen Sodium? API Revenue Market Share by Application (2021-2026)
Table 29. Global Ibuprofen Sodium? API Sale Price by Application (2021-2026) & (US$/Ton)
Table 30. Global Ibuprofen Sodium? API Sales by Company (2021-2026) & (Tons)
Table 31. Global Ibuprofen Sodium? API Sales Market Share by Company (2021-2026)
Table 32. Global Ibuprofen Sodium? API Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Ibuprofen Sodium? API Revenue Market Share by Company (2021-2026)
Table 34. Global Ibuprofen Sodium? API Sale Price by Company (2021-2026) & (US$/Ton)
Table 35. Key Manufacturers Ibuprofen Sodium? API Producing Area Distribution and Sales Area
Table 36. Players Ibuprofen Sodium? API Products Offered
Table 37. Ibuprofen Sodium? API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Ibuprofen Sodium? API Sales by Geographic Region (2021-2026) & (Tons)
Table 41. Global Ibuprofen Sodium? API Sales Market Share Geographic Region (2021-2026)
Table 42. Global Ibuprofen Sodium? API Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Ibuprofen Sodium? API Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Ibuprofen Sodium? API Sales by Country/Region (2021-2026) & (Tons)
Table 45. Global Ibuprofen Sodium? API Sales Market Share by Country/Region (2021-2026)
Table 46. Global Ibuprofen Sodium? API Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Ibuprofen Sodium? API Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Ibuprofen Sodium? API Sales by Country (2021-2026) & (Tons)
Table 49. Americas Ibuprofen Sodium? API Sales Market Share by Country (2021-2026)
Table 50. Americas Ibuprofen Sodium? API Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Ibuprofen Sodium? API Sales by Type (2021-2026) & (Tons)
Table 52. Americas Ibuprofen Sodium? API Sales by Application (2021-2026) & (Tons)
Table 53. APAC Ibuprofen Sodium? API Sales by Region (2021-2026) & (Tons)
Table 54. APAC Ibuprofen Sodium? API Sales Market Share by Region (2021-2026)
Table 55. APAC Ibuprofen Sodium? API Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Ibuprofen Sodium? API Sales by Type (2021-2026) & (Tons)
Table 57. APAC Ibuprofen Sodium? API Sales by Application (2021-2026) & (Tons)
Table 58. Europe Ibuprofen Sodium? API Sales by Country (2021-2026) & (Tons)
Table 59. Europe Ibuprofen Sodium? API Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Ibuprofen Sodium? API Sales by Type (2021-2026) & (Tons)
Table 61. Europe Ibuprofen Sodium? API Sales by Application (2021-2026) & (Tons)
Table 62. Middle East & Africa Ibuprofen Sodium? API Sales by Country (2021-2026) & (Tons)
Table 63. Middle East & Africa Ibuprofen Sodium? API Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Ibuprofen Sodium? API Sales by Type (2021-2026) & (Tons)
Table 65. Middle East & Africa Ibuprofen Sodium? API Sales by Application (2021-2026) & (Tons)
Table 66. Key Market Drivers & Growth Opportunities of Ibuprofen Sodium? API
Table 67. Key Market Challenges & Risks of Ibuprofen Sodium? API
Table 68. Key Industry Trends of Ibuprofen Sodium? API
Table 69. Ibuprofen Sodium? API Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Ibuprofen Sodium? API Distributors List
Table 72. Ibuprofen Sodium? API Customer List
Table 73. Global Ibuprofen Sodium? API Sales Forecast by Region (2027-2032) & (Tons)
Table 74. Global Ibuprofen Sodium? API Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Ibuprofen Sodium? API Sales Forecast by Country (2027-2032) & (Tons)
Table 76. Americas Ibuprofen Sodium? API Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Ibuprofen Sodium? API Sales Forecast by Region (2027-2032) & (Tons)
Table 78. APAC Ibuprofen Sodium? API Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Ibuprofen Sodium? API Sales Forecast by Country (2027-2032) & (Tons)
Table 80. Europe Ibuprofen Sodium? API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Ibuprofen Sodium? API Sales Forecast by Country (2027-2032) & (Tons)
Table 82. Middle East & Africa Ibuprofen Sodium? API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Ibuprofen Sodium? API Sales Forecast by Type (2027-2032) & (Tons)
Table 84. Global Ibuprofen Sodium? API Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Ibuprofen Sodium? API Sales Forecast by Application (2027-2032) & (Tons)
Table 86. Global Ibuprofen Sodium? API Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Xinhua Pharmaceutical Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 88. Xinhua Pharmaceutical Ibuprofen Sodium? API Product Portfolios and Specifications
Table 89. Xinhua Pharmaceutical Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Xinhua Pharmaceutical Main Business
Table 91. Xinhua Pharmaceutical Latest Developments
Table 92. IOLCP Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 93. IOLCP Ibuprofen Sodium? API Product Portfolios and Specifications
Table 94. IOLCP Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. IOLCP Main Business
Table 96. IOLCP Latest Developments
Table 97. Granules Biocause Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 98. Granules Biocause Ibuprofen Sodium? API Product Portfolios and Specifications
Table 99. Granules Biocause Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Granules Biocause Main Business
Table 101. Granules Biocause Latest Developments
Table 102. Strides Shasun Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 103. Strides Shasun Ibuprofen Sodium? API Product Portfolios and Specifications
Table 104. Strides Shasun Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Strides Shasun Main Business
Table 106. Strides Shasun Latest Developments
Table 107. BASF Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 108. BASF Ibuprofen Sodium? API Product Portfolios and Specifications
Table 109. BASF Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. BASF Main Business
Table 111. BASF Latest Developments
Table 112. SI Group Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 113. SI Group Ibuprofen Sodium? API Product Portfolios and Specifications
Table 114. SI Group Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 115. SI Group Main Business
Table 116. SI Group Latest Developments
Table 117. Hisoar Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 118. Hisoar Ibuprofen Sodium? API Product Portfolios and Specifications
Table 119. Hisoar Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 120. Hisoar Main Business
Table 121. Hisoar Latest Developments
Table 122. Granules India Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 123. Granules India Ibuprofen Sodium? API Product Portfolios and Specifications
Table 124. Granules India Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 125. Granules India Main Business
Table 126. Granules India Latest Developments
Table 127. SMS Pharmaceuticals Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 128. SMS Pharmaceuticals Ibuprofen Sodium? API Product Portfolios and Specifications
Table 129. SMS Pharmaceuticals Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 130. SMS Pharmaceuticals Main Business
Table 131. SMS Pharmaceuticals Latest Developments
Table 132. Luna Chemical Industries Basic Information, Ibuprofen Sodium? API Manufacturing Base, Sales Area and Its Competitors
Table 133. Luna Chemical Industries Ibuprofen Sodium? API Product Portfolios and Specifications
Table 134. Luna Chemical Industries Ibuprofen Sodium? API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 135. Luna Chemical Industries Main Business
Table 136. Luna Chemical Industries Latest Developments

LIST OF FIGURES

Figure 1. Picture of Ibuprofen Sodium? API
Figure 2. Ibuprofen Sodium? API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ibuprofen Sodium? API Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Ibuprofen Sodium? API Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ibuprofen Sodium? API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ibuprofen Sodium? API Sales Market Share by Country/Region (2025)
Figure 10. Ibuprofen Sodium? API Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of USP
Figure 12. Product Picture of EP
Figure 13. Global Ibuprofen Sodium? API Sales Market Share by Type in 2026
Figure 14. Global Ibuprofen Sodium? API Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Standard Crystalline
Figure 16. Product Picture of Micronized
Figure 17. Global Ibuprofen Sodium? API Sales Market Share by Physical Processing in 2026
Figure 18. Global Ibuprofen Sodium? API Revenue Market Share by Physical Processing (2021-2026)
Figure 19. Product Picture of Regulated-Market
Figure 20. Product Picture of General GMP Export
Figure 21. Product Picture of Other
Figure 22. Global Ibuprofen Sodium? API Sales Market Share by Regulatory Market Positioning in 2026
Figure 23. Global Ibuprofen Sodium? API Revenue Market Share by Regulatory Market Positioning (2021-2026)
Figure 24. Ibuprofen Sodium? API Consumed in Tablet
Figure 25. Global Ibuprofen Sodium? API Market: Tablet (2021-2026) & (Tons)
Figure 26. Ibuprofen Sodium? API Consumed in Capsule
Figure 27. Global Ibuprofen Sodium? API Market: Capsule (2021-2026) & (Tons)
Figure 28. Ibuprofen Sodium? API Consumed in Suspension
Figure 29. Global Ibuprofen Sodium? API Market: Suspension (2021-2026) & (Tons)
Figure 30. Ibuprofen Sodium? API Consumed in Other
Figure 31. Global Ibuprofen Sodium? API Market: Other (2021-2026) & (Tons)
Figure 32. Global Ibuprofen Sodium? API Sale Market Share by Application (2025)
Figure 33. Global Ibuprofen Sodium? API Revenue Market Share by Application in 2025
Figure 34. Ibuprofen Sodium? API Sales by Company in 2025 (Tons)
Figure 35. Global Ibuprofen Sodium? API Sales Market Share by Company in 2025
Figure 36. Ibuprofen Sodium? API Revenue by Company in 2025 ($ millions)
Figure 37. Global Ibuprofen Sodium? API Revenue Market Share by Company in 2025
Figure 38. Global Ibuprofen Sodium? API Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Ibuprofen Sodium? API Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Ibuprofen Sodium? API Sales 2021-2026 (Tons)
Figure 41. Americas Ibuprofen Sodium? API Revenue 2021-2026 ($ millions)
Figure 42. APAC Ibuprofen Sodium? API Sales 2021-2026 (Tons)
Figure 43. APAC Ibuprofen Sodium? API Revenue 2021-2026 ($ millions)
Figure 44. Europe Ibuprofen Sodium? API Sales 2021-2026 (Tons)
Figure 45. Europe Ibuprofen Sodium? API Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Ibuprofen Sodium? API Sales 2021-2026 (Tons)
Figure 47. Middle East & Africa Ibuprofen Sodium? API Revenue 2021-2026 ($ millions)
Figure 48. Americas Ibuprofen Sodium? API Sales Market Share by Country in 2025
Figure 49. Americas Ibuprofen Sodium? API Revenue Market Share by Country (2021-2026)
Figure 50. Americas Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
Figure 51. Americas Ibuprofen Sodium? API Sales Market Share by Application (2021-2026)
Figure 52. United States Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Ibuprofen Sodium? API Sales Market Share by Region in 2025
Figure 57. APAC Ibuprofen Sodium? API Revenue Market Share by Region (2021-2026)
Figure 58. APAC Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
Figure 59. APAC Ibuprofen Sodium? API Sales Market Share by Application (2021-2026)
Figure 60. China Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 64. India Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Ibuprofen Sodium? API Sales Market Share by Country in 2025
Figure 68. Europe Ibuprofen Sodium? API Revenue Market Share by Country (2021-2026)
Figure 69. Europe Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
Figure 70. Europe Ibuprofen Sodium? API Sales Market Share by Application (2021-2026)
Figure 71. Germany Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 72. France Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Ibuprofen Sodium? API Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Ibuprofen Sodium? API Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Ibuprofen Sodium? API Sales Market Share by Application (2021-2026)
Figure 79. Egypt Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Ibuprofen Sodium? API Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Ibuprofen Sodium? API in 2026
Figure 85. Manufacturing Process Analysis of Ibuprofen Sodium? API
Figure 86. Industry Chain Structure of Ibuprofen Sodium? API
Figure 87. Channels of Distribution
Figure 88. Global Ibuprofen Sodium? API Sales Market Forecast by Region (2027-2032)
Figure 89. Global Ibuprofen Sodium? API Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Ibuprofen Sodium? API Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Ibuprofen Sodium? API Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Ibuprofen Sodium? API Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Ibuprofen Sodium? API Revenue Market Share Forecast by Application (2027-2032)